Protalix Biotherapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.98

-0.02 (-1.00%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +1,476.3% upside

Low Target $17.92

Average Target $31.21

High Target $31.70

Current Price $1.98

Current
$1.98

Target
$31.21

$17.92 $31.21 avg $31.70

Scenario Analysis

Bear Case

$17.92

805.1%

Low target

Base Case

$31.21

+1,476.3%

Avg target

Bull Case

$31.70

+1,501.0%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$3.19

-37.9% from high

52-Week Low

$1.32

+50.0% from low

Target vs 52W High

$31.21

+878.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+20.5%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.2%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+178.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.1%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-88.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-23.9%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.0%